INSIGHT & ANALYSIS

Our Recent Publications Include:

Y Combinator Releases New "Post-Money" Forms of Safes

Five Questions to Determine If You Have a CFIUS Filing Requirement

Selected Favorable Pharmaceutical Intellectual Property Provisions of the USMCA

Overview of the Patent Landscape in the Blockchain, Cryptocurrency, and Cryptographic Token Space

Getting to a Fully Operational Token Platform

Delaware Court of Chancery Finds a Material Adverse Effect and Permits Termination of Merger Agreement

California Mandates Female Representation on Boards of Directors

Massachusetts Becomes 49th State to Adopt Uniform Trade Secrets Act

IRS May Relax Collection of Income Prong of Section 355 Active Trade or Business Test for R&D Companies

Regulation A+ Offerings for Tokens: What is the SEC Waiting For?

2018 Mid-Year Technology and Life Sciences IPO Report

The Life Sciences Report - Fall/Winter 2018

The PTAB Review - September 2018

District Court Case Highlights Nuances Associated with Determining If a Generic or Biosimilar Applicant Is Entitled to Protection of the Non-Infringement Safe Harbor

IRS Issues Guidance on Code Section 162(m) Including Grandfathered Arrangements and Covered Employees

Regulation A+ Offerings for Tokens:What is the SEC Waiting For?

Massachusetts Imposes Significant Restrictions on Post-Employment Non-Competition Covenants

FDA Publishes Biosimilars Action Plan (BAP)

Three-and-a-Half CFIUS Issues Needing Immediate Attention: Why Thinking "Big Whoop" Could Lead to Big Trouble

India Reporting and Registration Requirement Updates

FDA Pulls Back the Veil on Surrogate Endpoints

FDA Opens the Door for a Broader Range of Over-the-Counter (OTC) Drugs

California Supreme Court Rejects Employer Argument that It Need Not Pay for De Minimis Amounts of Time Worked by Employees

Why the SEC Thinks Most Tokens Are Securities And When the SEC Thinks a Token Might Stop Being a Security

Federal Circuit Reverses and Remands Alta Wind CaseHolding that a Portion of the Asserted Section 1603 Basis May be Allocable to Intangibles

SEC Amends Rule 701 to Increase Rule 701 Disclosure Threshold to $10 Million

 

Search by:
Publications:
Practice Area:
Publish Date:
    

 

On-Demand Learning


Related Information


WSGR Subscription Center